Economy
Agreement Inked To Establish Vaccines Factory In Khazaen City Worth RO20M
Khazaen Economic City signed an agreement with Opal For Biopharmaceuticals and Business Company to establish a factory for the production of biological human vaccines to the tune of RO20mn.
The first phase of the project will be set up on a total area of 37,000 square meters.

The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal For Biopharmaceuticals and Business Company.
Al Thuhli said that this project will be the first vaccines factory in Khazaen Economic City and it targets local and international markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
-
Economy2 weeks agoNumber of Workers in GCC Countries Increase From 2021 to 2025
-
OER Magazines3 weeks agoDossier Oman: Banking, Finance & Insurance Special Edition
-
Banking & Finance2 months agoSohar International Contributes OMR100,000 to Support Those Affected by Al Masarrat Weather Conditions
-
OER Magazines2 months agoOER, March 26
-
Oman1 week agoREVIEW: WHOOP and the Rise of Performance Luxury
-
News2 months agoReal Estate Price Index in Oman Grows By 13.9%
-
Economy1 month agoOPINION: War, Climate, and the Costs We Choose Not to See
-
News1 month agoHussain Al Maimani Joins MHD Infotech as Senior General Manager
